Siemens DR - Search Results

1

Patterns of referral for perioperative chemotherapy among patients with muscle-invasive bladder cancer: a population-based study.

Booth CM, Siemens DR, Peng Y, Mackillop WJ. Booth CM, et al. Among authors: siemens dr. Urol Oncol. 2014 Nov;32(8):1200-8. doi: 10.1016/j.urolonc.2014.05.012. Epub 2014 Jun 23. Urol Oncol. 2014. PMID: 24968946

2

A population-based study of the waiting times for prostatectomy in Ontario.

Siemens DR, Schulze KM, Mackillop WJ, Brundage MD, Groome PA. Siemens DR, et al. Can J Urol. 2005 Apr;12(2):2568-74. Can J Urol. 2005. PMID: 15877937

3

Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent.

Boulos DL, Groome PA, Brundage MD, Siemens DR, Mackillop WJ, Heaton JP, Schulze KM, Rohland SL. Boulos DL, et al. Among authors: siemens dr. Cancer. 2006 Apr 15;106(8):1804-14. doi: 10.1002/cncr.21813. Cancer. 2006. PMID: 16534794 Free article.

4

Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates.

Groome PA, Rohland SL, Siemens DR, Brundage MD, Heaton J, Mackillop WJ. Groome PA, et al. Among authors: siemens dr. Cancer. 2011 Sep 1;117(17):3943-52. doi: 10.1002/cncr.25984. Epub 2011 Feb 24. Cancer. 2011. PMID: 21858801 Free article.

5

Quality of care indicators and their related outcomes: a population-based study in prostate cancer patients treated with radiotherapy.

Webber C, Brundage MD, Siemens DR, Groome PA. Webber C, et al. Among authors: siemens dr. Radiother Oncol. 2013 Jun;107(3):358-65. doi: 10.1016/j.radonc.2013.04.017. Epub 2013 May 27. Radiother Oncol. 2013. PMID: 23722081

6

Prostate cancer-specific survival differences in patients treated by radical prostatectomy versus curative radiotherapy.

Degroot JM, Brundage MD, Lam M, Rohland SL, Heaton J, Mackillop WJ, Siemens DR, Groome PA. Degroot JM, et al. Among authors: siemens dr. Can Urol Assoc J. 2013 May-Jun;7(5-6):E299-305. doi: 10.5489/cuaj.11294. Epub 2013 May 13. Can Urol Assoc J. 2013. PMID: 23766831 Free PMC article.

7

Why is perioperative chemotherapy for bladder cancer underutilized?

Patafio FM, Mackillop WJ, Feldman-Stewart D, Siemens DR, Booth CM. Patafio FM, et al. Among authors: siemens dr. Urol Oncol. 2014 May;32(4):391-5. doi: 10.1016/j.urolonc.2013.11.003. Epub 2014 Feb 6. Urol Oncol. 2014. PMID: 24508282 Review.

8

Perioperative chemotherapy for muscle-invasive bladder cancer: A population-based outcomes study.

Booth CM, Siemens DR, Li G, Peng Y, Tannock IF, Kong W, Berman DM, Mackillop WJ. Booth CM, et al. Among authors: siemens dr. Cancer. 2014 Jun 1;120(11):1630-8. doi: 10.1002/cncr.28510. Epub 2014 Apr 14. Cancer. 2014. PMID: 24733278 Free article.

9

Delivery of perioperative chemotherapy for bladder cancer in routine clinical practice.

Booth CM, Siemens DR, Peng Y, Tannock IF, Mackillop WJ. Booth CM, et al. Among authors: siemens dr. Ann Oncol. 2014 Sep;25(9):1783-1788. doi: 10.1093/annonc/mdu204. Epub 2014 Jun 10. Ann Oncol. 2014. PMID: 24915872 Free article.

10

Curative therapy for bladder cancer in routine clinical practice: a population-based outcomes study.

Booth CM, Siemens DR, Li G, Peng Y, Kong W, Berman DM, Mackillop WJ. Booth CM, et al. Among authors: siemens dr. Clin Oncol (R Coll Radiol). 2014 Aug;26(8):506-14. doi: 10.1016/j.clon.2014.05.007. Epub 2014 Jun 20. Clin Oncol (R Coll Radiol). 2014. PMID: 24954284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters